Key Record Dates
| ClinicalTrials.gov Identifier: | NCT04435366 |
|---|---|
| Brief Title: | A Phase 3 Safety and Efficacy Study of Intravitreal Administration of Zimura (Complement C5 Inhibitor) |
| First Submitted : | May 12, 2020 |
| First Submitted that Met QC Criteria : | June 15, 2020 |
| First Posted : | June 17, 2020 |
| Results First Submitted : | November 1, 2023 |
| Results First Posted with QC Comments : | November 22, 2023 |
| Results First Submitted that Met QC Criteria : | December 7, 2023 |
| Results First Posted : | December 28, 2023 |
| Certification/Extension First Submitted : | July 21, 2023 |
| Certification/Extension First Posted : | December 28, 2023 |
| Last Update Submitted that Met QC Criteria : | February 20, 2024 |
| Last Update Posted : | February 23, 2024 |